Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Jun. 30, 2012	Jun. 25, 2011	Jun. 26, 2010
Cash Flows From (For) Operating Activities
Net income	$ 401,613	$ 339,197	$ 223,799
Adjustments to derive cash flows
Write-off of in-process research and development	0	0	19,000
Gain on sale of pipeline development projects	(3,500)	0	0
(Gain) loss on sale of business	(8,639)	2,151	(750)
Restructuring Costs and Asset Impairment Charges	8,668	1,033	9,523
Depreciation and amortization	135,323	102,941	74,104
Share-based compensation	18,973	15,355	14,696
Income tax benefit from exercise of stock options	(1,796)	(623)	(1,302)
Excess tax benefit of stock transactions	(12,893)	(17,193)	(9,860)
Deferred income taxes	27,476	(56,140)	(16,073)
Subtotal	565,225	386,721	313,137
Changes in operating assets and liabilities, net of asset and business acquisitions and disposition
Accounts receivable	(49,349)	(107,235)	(21,766)
Inventories	5,353	(30,416)	(32,217)
Accounts payable	(23,555)	57,804	(1,558)
Payroll and related taxes	4,988	616	30,917
Accrued customer programs	(1,568)	31,440	5,142
Accrued liabilities	4,203	(32,335)	7,451
Accrued income taxes	13,746	56,216	26,310
Other	(5,667)	11,150	4,947
Subtotal	(51,849)	(12,760)	19,226
Net cash from operating activities	513,376	373,961	332,363
Cash Flows (For) From Investing Activities
Acquired research and development	0	0	(19,000)
Acquisitions of businesses, net of cash acquired	(582,329)	2,624	(868,802)
Additions to property and equipment	(120,192)	(99,443)	(57,816)
Proceeds from sale of intangible assets and pipeline development projects	10,500	0	0
(Return of) proceeds from sale of business	8,639	(3,558)	35,980
Acquisitions of assets	(750)	(10,750)	(10,262)
Proceeds from sales of securities	0	560	0
Net cash for investing activities	(684,132)	(110,567)	(919,900)
Cash Flows (For) From Financing Activities
Repayments of short-term debt, net	(2,680)	(6,230)	(8,771)
Borrowings of long-term debt	1,089,235	150,000	625,000
Repayments of long-term debt	(610,000)	(195,000)	(165,000)
Deferred financing fees	(5,097)	(5,483)	(5,813)
Excess tax benefit of stock transactions	12,893	17,193	9,860
Issuance of common stock	11,621	14,341	21,444
Repurchase of common stock	(8,236)	(8,308)	(71,088)
Cash dividends	(29,021)	(25,303)	(22,329)
Net cash (for) from financing activities	458,715	(58,790)	383,303
Effect of exchange rate changes on cash	4,426	(4,265)	(3,643)
Net increase (decrease) in cash and cash equivalents	292,385	200,339	(207,877)
Cash and cash equivalents of continuing operations, beginning of period	310,104		109,765
Cash balance of discontinued operations, beginning of period	0		0
Cash and cash equivalents, end of period	602,489	310,104	109,765
Cash and cash equivalents of continuing operations, end of period	602,489	310,104
Cash paid/received during the year for:
Interest paid	53,694	47,455	53,557
Interest received	3,989	3,726	21,392
Income taxes paid	82,338	115,627	77,420
Income taxes refunded	$ 910	$ 1,440	$ 1,433